PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New pig model will provide insights into early detection, new treatments of cancers

2015-07-30
(Press-News.org) URBANA, Ill. - With many types of cancers, early detection offers the best hope for survival. However, research into new early-detection screenings, as well as possible interventional radiology and surgical treatments, has been hindered by the lack of a large animal model that would accurately reflect the types of cancers seen in human cells.

For the last several years, researchers at the University of Illinois interested in improving screening programs for cancer have studied gene expression in mice, humans, and pigs in an effort to create a large-animal model that is more relevant to human cancers.

A new study from U of I researchers and other collaborators, recently published in PLOS One, reports the creation of such a model--a genetically engineered pig that allows researchers to induce the development of the same types of tumors seen in humans, reflecting the gene pathways and gene mutations most often observed in human cancer. Due to the genetic engineering, the tumors can be induced at any tissue site at any given time.

Lawrence Schook, a geneticist in the U of I Department of Animal Sciences, said that the "oncopig" model holds great promise not only in understanding and detecting cancer earlier, but also in developing new treatments and possible cures.

"We already knew which mutations cause cancer, but we wanted a model that would allow us to look for early detection of cancers," Schook said. "Currently, if a patient is diagnosed with stage 3 or 4 of certain types of cancer, it is often too late for drug, radiation, or surgical interventions. If we could induce tumors in various tissues at very specific times, we could come up with early diagnoses and screening tools. That will allow us, if you have early onset cancer, to do something early on in the progression of the cancer. That's been our goal."

Schook said the researchers are especially targeting cancers that are more difficult to diagnose in their early stages, including pancreatic, liver, lung, and bladder cancers. "These are devastating diseases for which early detection is critical. If we could detect them earlier, we have ways to treat them," he said.

During a decade-long collaboration with Professor Christopher Counter at Duke University, Schook said researchers identified the pig as a better model than mice because of the pig's similarities in anatomy, size, metabolism, and genetics to humans. And although the mice in their previous studies did develop tumors, the tumors were not similar to the tumors clinically observed in humans. And treatments, such as radiation or surgery, are simply not scalable to mice.

"Many people who are diagnosed with liver, pancreatic, or lung cancer, for example, have either been smokers or drinkers, or are overweight, or have cardiovascular disease. These are comorbidities. With the pig model, we can induce comorbidities in pigs. We can induce tumors in tissue that would be very similar to clinical human tumors," Schook said.

In the researchers' first paper, they described isolating fibroblasts from pigs, inserting the genes with the mutations into these cells, and testing for tumor formation in the donor pig's ear. "We know that those mutations cause tumors in humans, so we asked if we would see that in pigs and the answer was yes. It was the same pathway, the same genes, and the same mutation," he said.

Schook explained that because mutations in the genes (KRAS or TP53) are seen in nearly 50 percent of all human cancer, they targeted those genes in the pig model. The researchers engineered a construct of the pig genes with the added mutations. Because this construct is not expressed in normal cells, they "activated" expression of the mutated genes with an injection of a Cre recombinase enzyme, which induces tumors by signaling the gene to recombine.

"The pigs that are born with this gene inserted in them are normal animals, and if we expose a particular cell to this Cre enzyme, it gets activated and becomes tumorigenic. We can have control over the cell, as well as the location and the timing of inducing this signal," Schook explained. "We can target individual cells or tissues."

Depending on the location of injection, Schook said different types of tumors developed in the model. "It was what we expected. It was a proof of concept," he noted.

Because of the ability to target individual locations, the model is applicable to a range of types of cancers. "It also allows us to develop approaches to treating different cancers, depending on where they are located in the body," Schook explained. "We can begin to look at location and interventional radiology and microsurgery."

Along with strong the collaboration with Counter at Duke University, Schook said the University of Missouri's National Swine Resource and Research Center (NSRRC), supported by the National Institutes of Health (NIH), contributed to the project.

"We're excited that this pig is a national and international model that will be available to anybody doing research. They can get the model through the NSRRC," he said.

Schook and Laurie Rund, a research assistant professor in animal sciences, have also collaborated for several years with Champaign-Urbana-based Acoustic MedSystems, a medical device research and development company, in evaluating new image-guided minimally invasive ablative surgical methods.

"Currently, all the minimal invasive devices in the clinic or currently under investigation have never been tested in human-scale large-animal tumor models. All device testing has used normal tissues," Schook said. "This model essentially offers the opportunity to evaluate new therapies and devices in a human-size animal model."

Because of the "oncopig" model, Acoustic MedSystems (AMS) has developed several image-guided minimally invasive devices for treatment of tumors in several sites, including liver, kidney, spine, prostate, and brain. Recently, U of I and AMS piloted the use of the oncogenic pig model for evaluating a new high-intensity ultrasound therapy system for soft tissue tumors, culminating in the submission of a research proposal to the National Cancer Institute that proposes to induce tumor growth in genetically engineered oncogenic pigs and assess the treatment efficacy of 3D spatially registered image-guided catheter-based ultrasound thermal surgery. The project will be a collaborative partnership grant between AMS and U of I, with principal investigators Schook, Rund, and Everette C. Burdette of AMS.

"Success of the proposed work using the new tumor model in a large animal that is comparable in both scale and physiology to human patients will be beneficial to validate many minimally invasive modalities in addition to ultrasound therapy, but also other energy-based modalities including cryo-ablation, radiofrequency and microwave thermal therapy," the researchers reported in the proposal. "The validation test results from the model will ensure greater safety and permit treatment response evaluation prior to first-in-human clinical studies."

INFORMATION:

"A genetic porcine model of cancer" was recently published in PLOS One. Co-authors include Lawrence B. Schook , Tiago V. Collares, Wenping Hu, Ying Liang, Fernanda M. Rodrigues, Laurie A. Rund, Kyle M. Schachtschneider, Fabiana K. Seixas, Kuldeep Singh, Kevin D. Wells, Eric M. Walters, Randall S. Prather, and Christopher M. Counter.



ELSE PRESS RELEASES FROM THIS DATE:

State immunization laws should eliminate non-medical exemptions, say internists

2015-07-29
Support for eliminating existing exemptions, except for medical reasons, from immunization laws was among the policy recommendations adopted last weekend at the summer meeting of the Board of Regents of the American College of Physicians (ACP). "Allowing exemptions based on non-medical reasons poses a risk both to the unvaccinated person and to public health," said Wayne J. Riley, MD, MPH, MBA, MACP, president of ACP, "Intentionally unvaccinated individuals can pose a danger to the public, especially to individuals who cannot be vaccinated for medical reasons." The ...

Targeted therapy shows effectiveness against a subtype of the brain tumor medulloblastoma

Targeted therapy shows effectiveness against a subtype of the brain tumor medulloblastoma
2015-07-29
A targeted therapy already used to treat advanced skin cancer is also effective against the most common subtype of the brain tumor medulloblastoma in adults and should be considered for treatment of newly diagnosed patients, according to research led by St. Jude Children's Research Hospital. The drug, called vismodegib, is designed to block a key protein in the sonic hedgehog (SHH) signaling pathway. The pathway is normally active during fetal development and is inappropriately switched on in about 30 percent of medulloblastoma tumors, including about 60 percent of tumors ...

Researchers design first artificial ribosome

2015-07-29
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell. The engineered ribosome may enable the production of new drugs and next-generation biomaterials and lead to a better understanding of how ribosomes function. The artificial ribosome, called Ribo-T, was created in the laboratories of Alexander Mankin, director of the UIC College of Pharmacy's Center for Biomolecular Sciences, ...

New research opens the door for treatment of relapsing bacterial infections

2015-07-29
It's one thing to grow bacteria in a test tube, perform a screen in the lab, and find a mutation in the pathogen's genes. It's a whole other thing, and much rarer, to find the exact same mutation in nature--in this case, in E. coli in urine samples from some 500 patients suffering from relapsing urinary tract infections. The confluent discovery, by University Distinguished Professor Kim Lewis and his colleagues, was published on Wednesday in the journal Nature. It could put people with relapsing UTIs on the fast track for a new therapeutic regimen that Lewis described ...

Playing 'tag' with pollution lets scientists see who's 'it'

Playing tag with pollution lets scientists see whos it
2015-07-29
RICHLAND, Wash. -- Using a climate model that can tag sources of soot from different global regions and can track where it lands on the Tibetan Plateau, researchers have determined which areas around the plateau contribute the most soot -- and where. The model can also suggest the most effective way to reduce soot on the plateau, easing the amount of warming the region undergoes. The work, which appeared in Atmospheric Chemistry and Physics in June, shows that soot pollution on and above the Himalayan-Tibetan Plateau area warms the region enough to contribute to earlier ...

New computer-based technology may lead to improvements in facial transplantation

2015-07-29
Following several years of research and collaboration, physicians and engineers at Johns Hopkins and Walter Reed National Military Medical Center say they have developed a computer platform that provides rapid, real-time feedback before and during facial transplant surgery, which may someday improve face-jaw-teeth alignment between donor and recipient. Surgeons performed the first successful transplant of facial features, including the jaw and teeth, in 2008, mainly relying on visual judgment. Since then, approximately 30 facial transplants have been done worldwide, ...

'Failed stars' host powerful auroral displays

Failed stars host powerful auroral displays
2015-07-29
Brown dwarfs are relatively cool, dim objects that are difficult to detect and hard to classify. They are too massive to be planets, yet possess some planetlike characteristics; they are too small to sustain hydrogen fusion reactions at their cores, a defining characteristic of stars, yet they have starlike attributes. By observing a brown dwarf 20 light-years away using both radio and optical telescopes, a team led by Gregg Hallinan, assistant professor of astronomy at Caltech, has found another feature that makes these so-called failed stars more like supersized planets--they ...

Scientists identify gene vital for rebuilding intestine after cancer treatment

2015-07-29
CHAPEL HILL, NC - The stem cells in our gut divide so fast that they create a completely new population of epithelial cells every week. But this quick division is also why radiation and chemotherapy wreak havoc on the gastrointestinal systems of cancer patients - such therapies target rapidly dividing cells. Scientists at the UNC School of Medicine and the UNC Lineberger Comprehensive Cancer Center found that a rare type of stem cell is immune to radiation damage thanks to high levels of a gene called Sox9. The discovery, which was made in mice and published in the journal ...

Experts recommend tumor removal as first-line treatment for Cushing's syndrome

2015-07-29
Washington, DC--The Endocrine Society today issued a Clinical Practice Guideline (CPG) on strategies for treating Cushing's syndrome, a condition caused by overexposure to the hormone cortisol. The CPG, entitled "Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline," was published online and will appear in the August 2015 print issue of the Journal of Clinical Endocrinology and Metabolism (JCEM), a publication of the Endocrine Society. Cushing's syndrome occurs when a person has excess cortisol in the blood for an extended period, according ...

RAND analysis shows more work needed to engage consumers after enrolling in health insurance plans

2015-07-29
Enrolling in an insurance plan under the Affordable Care Act is only the first step for consumers to be actively engaged in their health care, according to a new analysis from RAND Corporation researchers. To understand the issues facing consumers as well as the payers, providers and support organizations who work directly with them, RAND researchers conducted phone-based interviews with insurance companies, physician groups and community support nonprofit organizations. The analysis of the interviews shows more work is necessary to support consumers past the point of ...

LAST 30 PRESS RELEASES:

Call for papers: 14th Asia-Pacific Conference on Transportation and the Environment (APTE 2025)

A novel disturbance rejection optimal guidance method for enhancing precision landing performance of reusable rockets

New scan method unveils lung function secrets

Searching for hidden medieval stories from the island of the Sagas

Breakthrough study reveals bumetanide treatment restores early social communication in fragile X syndrome mouse model

Neuroscience leader reveals oxytocin's crucial role beyond the 'love hormone' label

Twelve questions to ask your doctor for better brain health in the new year

Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes

Study identifies genetic cause for yellow nail syndrome

New drug to prevent migraine may start working right away

Good news for people with MS: COVID-19 infection not tied to worsening symptoms

Department of Energy announces $179 million for Microelectronics Science Research Centers

Human-related activities continue to threaten global climate and productivity

Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued

Unraveling the power and influence of language

Gene editing tool reduces Alzheimer’s plaque precursor in mice

TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies

Twisted Edison: Bright, elliptically polarized incandescent light

Structural cell protein also directly regulates gene transcription

Breaking boundaries: Researchers isolate quantum coherence in classical light systems

Brain map clarifies neuronal connectivity behind motor function

Researchers find compromised indoor air in homes following Marshall Fire

Months after Colorado's Marshall Fire, residents of surviving homes reported health symptoms, poor air quality

Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology

'Glass fences' hinder Japanese female faculty in international research, study finds

Vector winds forecast by numerical weather prediction models still in need of optimization

New research identifies key cellular mechanism driving Alzheimer’s disease

Trends in buprenorphine dispensing among adolescents and young adults in the US

Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility

Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity

[Press-News.org] New pig model will provide insights into early detection, new treatments of cancers